Blog
RSS FeedPosted by Michael Wonder on 15 Jan 2020
Proposal to fund betamethasone dipropionate with calcipotriol (Enstilar) foam spray for psoriasis
15 January 2020 - PHARMAC is seeking feedback on a proposal to fund a new topical psoriasis medicine, betamethasone dipropionate ...
Posted by Michael Wonder on 12 Jan 2020
Atomoxetine – further delay in change of funded brand and open access
10 January 2020 - PHARMAC is advising all interested parties that there is a further delay in the listing of ...
Posted by Michael Wonder on 09 Jan 2020
PBS – 2019 in review
9 January 2020 - 16 'real world' new medicines were listed on the PBS in 2019. ...
Posted by Michael Wonder on 06 Jan 2020
New hope for breast cancer patients with key drug added to PBS
6 January 2020 - Australians living with advanced breast cancer now have access to an important new treatment option, with the ...
Posted by Michael Wonder on 04 Jan 2020
New drug added to PBS can double life expectancy for breast cancer
5 January 2020 - A new drug that can slow the progression of advanced breast cancer has been added to the ...
Posted by Michael Wonder on 02 Jan 2020
Schedule of Pharmaceutical Benefits - 1 January 2020 update
1 January 2020 - The January 2020 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 02 Jan 2020
Biosimilar trastuzumab and rituximab on the PBS - information for health professionals and patients
2 January 2019 - New biosimilar brands of trastuzumab (Ontruzant) and rituximab (Truxima) have listed on the PBS on 1 January ...
Posted by Michael Wonder on 02 Jan 2020
New laws that affect Australians from January 1, 2020
1 January 2020 - Today there are a raft of changes coming to welfare, health, education and many other living expenses. ...
Posted by Michael Wonder on 02 Jan 2020
New Zealand Pharmaceutical Schedule - 1 January 2020 update
2 January 2020 - The January 2020 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 05 Dec 2019
Decision to fund two new cancer treatments: olaparib and fulvestrant
5 December 2019 - PHARMAC is pleased to announce a decision to fund two new cancer treatments and amend the ...
Posted by Michael Wonder on 02 Dec 2019
Biosimilar trastuzumab on the PBS - information for health professionals and patients
2 December 2019 - A new biosimilar brand of trastuzumab (Kanjinti) has listed on the PBS on 1 December 2019. ...
Posted by Michael Wonder on 02 Dec 2019
Tasmanian man Robert Mitchell welcomes rollout of new drug Dovato on PBS
2 December 2019 - Robert Mitchell has been defying a medical diagnosis for nearly 30 years. Now a new drug will ...
Posted by Michael Wonder on 01 Dec 2019
Schedule of Pharmaceutical Benefits - 1 December 2019 update
1 December 2019 - The December 2019 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 01 Dec 2019
New hope for psoriasis sufferers as new drug Skyrizi added to PBS
1 December 2019 - Australians living with severe chronic psoriasis have been given renewed hope with the introduction of a new ...
Posted by Michael Wonder on 01 Dec 2019
New Zealand Pharmaceutical Schedule - 1 December 2019 update
1 December 2019 - The December 2019 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...